Jason Hafler
Directeur/Bestuurslid bij Buckingham Browne & Nichols School
Oorsprong van het eerstegraads netwerk van Jason Hafler
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Buckingham Browne & Nichols School
 Buckingham Browne & Nichols School Other Consumer ServicesConsumer Services Buckingham Browne & Nichols School provides education services. The company is headquartered in Cambridge, MA.
31
| Private Company | Other Consumer Services | 31 |
Abcuro, Inc.
 Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Abcuro, Inc. develops bio-therapeutics for the treatment of autoimmunity and cancer. the company was founded in 2015 and is headquartered in Newton, MA.
15
| Holding Company | Miscellaneous Commercial Services | 15 |
Sanofi Ventures
 Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts.
12
| Subsidiary | Investment Managers | 12 |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA.
10
| Subsidiary | Biotechnology | 10 |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA.
10
| Holding Company | Biotechnology | 10 |
Matchpoint Therapeutics, Inc.
 Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Matchpoint Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company aims to discover and develop precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. Matchpoint's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry library evolution. The company was founded by Jianwei Che, Edward Chouchani, Tinghu Zhang, Nathanael S. Gray, and the CEO is G. Andre Turenne.
7
| Holding Company | Biotechnology | 7 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.
7
| Private Company | Investment Managers | 7 |
Magdalene College
1
| College/University | Other Consumer Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jason Hafler via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Executive Officer | |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Founder | |
| RECEPTOS INC | Pharmaceuticals: Major | Founder Founder Director/Board Member | |
| AVROBIO, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director of Finance/CFO Chief Operating Officer | |
| University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| Boston University | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Brandeis University | College/University | Doctorate Degree Doctorate Degree | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Founder | |
| Beijing University of Chemical Technology | College/University | Graduate Degree Graduate Degree | |
Accomplice LLC
 Accomplice LLC Investment ManagersFinance Accomplice LLC (Accomplice) is a venture capital firm founded in 1980 by Ryan Robert Moore, Christopher Paul Lynch and Jeffrey Lyle Fagnan. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Founder | |
Shanghai ChemPartner Co., Ltd.
 Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai ChemPartner Co., Ltd. operates as a contract research organization. It provides chemistry, biology, pharmacology, DMPK, process R&D, pre-formulation, and analytical development services to global pharmaceutical and biotech companies. The company was founded in 2003 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Corporate Officer/Principal Founder | |
| LARIMAR THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| University of Michigan | College/University | Doctorate Degree Undergraduate Degree | |
New England Venture Capital Association, Inc.
 New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | President Director/Board Member | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Founder President | |
| DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman Director/Board Member | |
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IO BIOTECH, INC. | Biotechnology | Chairman Director/Board Member | |
| University of Illinois | College/University | Undergraduate Degree Doctorate Degree | |
| KALA BIO, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
Inmar-OIQ LLC
 Inmar-OIQ LLC Advertising/Marketing ServicesCommercial Services Inmar-OIQ LLC operates as a holding company, which engages in the operation as a network of channel focused websites to help consumers easily find self-support product information. It also offers advertising, direct marketing and market research services. The company was founded by Jay Habegger, Connie Johnson, Eric Mabley, Chris Back and Doug Shattuck in August 2006 and is headquartered in Boston, MA. | Advertising/Marketing Services | Director/Board Member Director/Board Member | |
IFM Therapeutics LLC
 IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology IFM Therapeutics LLC engages in the development and transformation of immunotherapy for patients with serious diseases. It focuses on developing small molecule drugs that target the innate immune system. The company was founded by Gary D. Glick, Luigi Franchi, Matthias Geyer, Eicke Latz, and Anthony W. Opipari, Jr. in 2015 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pretzel Therapeutics, Inc.
 Pretzel Therapeutics, Inc. BiotechnologyHealth Technology Pretzel Therapeutics, Inc. is an American biotechnology company that develops therapies by utilizing mitochondrial biology. Pretzel Therapeutics is based in an undisclosed location and has research facilities in another undisclosed location. The company aims to develop treatments that address the genetic causes of mitochondrial dysfunction. The company was founded by academic experts in mitochondrial biology and is supported by a world-class investor syndicate. Jay Parrish has been the CEO of the company since 2021. | Biotechnology | Director/Board Member Chief Executive Officer | |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Biotechnology | Founder Consultant / Advisor | |
Exonics Therapeutics, Inc.
 Exonics Therapeutics, Inc. BiotechnologyHealth Technology Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| Haas School of Business | College/University | Masters Business Admin Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 45 |
| China | 3 |
| Denemarken | 3 |
| Israël | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 14 |
| Commercial Services | 7 |
| Finance | 3 |
| Miscellaneous | 2 |
Operationeel
| Director/Board Member | 471 |
| Corporate Officer/Principal | 132 |
| Independent Dir/Board Member | 77 |
| Private Equity Investor | 67 |
| Chairman | 62 |
Sterkste connecties
| Insiders | |
|---|---|
| Bruce Booth | 40 |
| Kristina Burow | 40 |
| Ryan Moore | 38 |
| Christopher Lynch | 38 |
| Joshua Resnick | 36 |
| Jeffrey S. Barber | 29 |
| Robert Higgins | 29 |
| Axel Bichara | 26 |
| Charles A. Brizius | 25 |
| Krishna Yeshwant | 25 |
| Darlene Deptula-Hicks | 24 |
| Michael Gladstone | 23 |
| Steven Kafka | 19 |
| Bernard Davitian | 19 |
| Alex Martin Martin | 19 |
- Beurs
- Insiders
- Jason Hafler
- Bedrijfsconnecties
